logo
A common assumption about ageing may be wrong, study suggests

A common assumption about ageing may be wrong, study suggests

CNA2 days ago
A new analysis of data gathered from a small indigenous population in the Bolivian Amazon suggests some of our basic assumptions about the biological process of ageing might be wrong.
Inflammation is a natural immune response that protects the body from injury or infection. Scientists have long believed that long-term, low-grade inflammation – also known as 'inflammageing' – is a universal hallmark of getting older. But this new data raises the question of whether inflammation is directly linked to ageing at all, or if it's linked to a person's lifestyle or environment instead.
The study, which was published recently, found that people in two non-industrialised areas experienced a different kind of inflammation throughout their lives than more urban people – likely tied to infections from bacteria, viruses and parasites rather than the precursors of chronic disease. Their inflammation also didn't appear to increase with age.
Scientists compared inflammation signals in existing data sets from four distinct populations in Italy, Singapore, Bolivia and Malaysia; because they didn't collect the blood samples directly, they couldn't make exact apples-to-apples comparisons.
But if validated in larger studies, the findings could suggest that diet, lifestyle and environment influence inflammation more than ageing itself, said Alan Cohen, an author of the paper and an associate professor of environmental health sciences at Columbia University.
'Inflammageing may not be a direct product of aging, but rather a response to industrialised conditions,' he said, adding that this was a warning to experts like him that they might be overestimating its pervasiveness globally.
'How we understand inflammation and ageing health is based almost entirely on research in high-income countries like the US,' said Thomas McDade, a biological anthropologist at Northwestern University. But a broader look shows that there's much more global variation in ageing than scientists previously thought, he added.
The study 'sparks valuable discussion' but needs much more follow-up 'before we rewrite the inflammageing narrative,' said Bimal Desai, a professor of pharmacology who studies inflammation at the University of Virginia School of Medicine.
INFLAMMATION IS DIFFERENT IN DIFFERENT PLACES
In the study, researchers compared blood samples from about 2,800 adults between 18 and 95. People in the more industrialised Chianti region of Italy and in Singapore both showed the types of proteins that signal inflammageing.
The Tsimane group in Bolivia and the Orang Asli group in Malaysia, on the other hand, had different inflammatory markers likely tied to infections, instead of the proteins marking inflammageing. (The four datasets used blood samples with subjects' informed consent, whether written or verbal, and institutional approval.)
The fact that inflammation markers looked so similar in groups from industrialised regions, but so different from the others, is striking, said Aurelia Santoro, an associate professor at the University of Bologna who was not involved in the study. 'This suggests that immune cells are activated in fundamentally different ways depending on context.'
The Tsimane population's protein markers were less linked to inflammageing than the Orang Asli's; authors speculated that this might be because of differences in lifestyle and diet.
Some experts questioned the findings' significance. Vishwa Deep Dixit, director of the Yale Center for Research on Aging, said it's not surprising that lifestyles with less exposure to pollution are linked to lower rates of chronic disease. 'This becomes a circular argument' that doesn't prove or disprove whether inflammation causes chronic disease, he said.
Either way, the findings need to be validated in larger, more diverse studies that follow people over time, experts said. While they had lower rates of chronic disease, the two Indigenous populations tended to have life spans shorter than those of people in industrialised regions, meaning they may simply not have lived long enough to develop inflammageing, Dr Santoro said.
THE PROBLEM MAY BE TIED TO URBAN LIVING
Because the study looked at protein markers in blood samples, and not specific lifestyle or diet differences among populations, scientists had to make educated guesses about why industrialised groups experience more inflammageing, Dr Cohen said.
Dr McDade, who has previously studied inflammation in the Tsimane group, speculated that populations in non-industrialised regions might be exposed to certain microbes in water, food, soil and domestic animals earlier in their lives, bolstering their immune response later in life.
At the same time, people in urbanised, industrial environments are 'exposed to a lot of pollutants and toxins,' many of which have ' demonstrated pro-inflammatory effects,' he said. Diet and lifestyle could also play a part: The Tsimane tend to live in small settlements with their extended family and eat a largely plant-based diet, he said.
There might also be good and bad types of inflammation, Dr Cohen said. While the indigenous populations did experience inflammation from infection, those levels weren't tied to chronic disease later in life. That could mean that the presence of inflammation alone isn't as bad as we thought, he added.
It's not clear if people can do anything to manage inflammageing late in life. People who want to age more healthily may be better off eating better and exercising more to regulate immune response in the long run, instead of focusing on drugs or supplements advertised to target inflammation, Dr Cohen said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

A common assumption about ageing may be wrong, study suggests
A common assumption about ageing may be wrong, study suggests

CNA

time2 days ago

  • CNA

A common assumption about ageing may be wrong, study suggests

A new analysis of data gathered from a small indigenous population in the Bolivian Amazon suggests some of our basic assumptions about the biological process of ageing might be wrong. Inflammation is a natural immune response that protects the body from injury or infection. Scientists have long believed that long-term, low-grade inflammation – also known as 'inflammageing' – is a universal hallmark of getting older. But this new data raises the question of whether inflammation is directly linked to ageing at all, or if it's linked to a person's lifestyle or environment instead. The study, which was published recently, found that people in two non-industrialised areas experienced a different kind of inflammation throughout their lives than more urban people – likely tied to infections from bacteria, viruses and parasites rather than the precursors of chronic disease. Their inflammation also didn't appear to increase with age. Scientists compared inflammation signals in existing data sets from four distinct populations in Italy, Singapore, Bolivia and Malaysia; because they didn't collect the blood samples directly, they couldn't make exact apples-to-apples comparisons. But if validated in larger studies, the findings could suggest that diet, lifestyle and environment influence inflammation more than ageing itself, said Alan Cohen, an author of the paper and an associate professor of environmental health sciences at Columbia University. 'Inflammageing may not be a direct product of aging, but rather a response to industrialised conditions,' he said, adding that this was a warning to experts like him that they might be overestimating its pervasiveness globally. 'How we understand inflammation and ageing health is based almost entirely on research in high-income countries like the US,' said Thomas McDade, a biological anthropologist at Northwestern University. But a broader look shows that there's much more global variation in ageing than scientists previously thought, he added. The study 'sparks valuable discussion' but needs much more follow-up 'before we rewrite the inflammageing narrative,' said Bimal Desai, a professor of pharmacology who studies inflammation at the University of Virginia School of Medicine. INFLAMMATION IS DIFFERENT IN DIFFERENT PLACES In the study, researchers compared blood samples from about 2,800 adults between 18 and 95. People in the more industrialised Chianti region of Italy and in Singapore both showed the types of proteins that signal inflammageing. The Tsimane group in Bolivia and the Orang Asli group in Malaysia, on the other hand, had different inflammatory markers likely tied to infections, instead of the proteins marking inflammageing. (The four datasets used blood samples with subjects' informed consent, whether written or verbal, and institutional approval.) The fact that inflammation markers looked so similar in groups from industrialised regions, but so different from the others, is striking, said Aurelia Santoro, an associate professor at the University of Bologna who was not involved in the study. 'This suggests that immune cells are activated in fundamentally different ways depending on context.' The Tsimane population's protein markers were less linked to inflammageing than the Orang Asli's; authors speculated that this might be because of differences in lifestyle and diet. Some experts questioned the findings' significance. Vishwa Deep Dixit, director of the Yale Center for Research on Aging, said it's not surprising that lifestyles with less exposure to pollution are linked to lower rates of chronic disease. 'This becomes a circular argument' that doesn't prove or disprove whether inflammation causes chronic disease, he said. Either way, the findings need to be validated in larger, more diverse studies that follow people over time, experts said. While they had lower rates of chronic disease, the two Indigenous populations tended to have life spans shorter than those of people in industrialised regions, meaning they may simply not have lived long enough to develop inflammageing, Dr Santoro said. THE PROBLEM MAY BE TIED TO URBAN LIVING Because the study looked at protein markers in blood samples, and not specific lifestyle or diet differences among populations, scientists had to make educated guesses about why industrialised groups experience more inflammageing, Dr Cohen said. Dr McDade, who has previously studied inflammation in the Tsimane group, speculated that populations in non-industrialised regions might be exposed to certain microbes in water, food, soil and domestic animals earlier in their lives, bolstering their immune response later in life. At the same time, people in urbanised, industrial environments are 'exposed to a lot of pollutants and toxins,' many of which have ' demonstrated pro-inflammatory effects,' he said. Diet and lifestyle could also play a part: The Tsimane tend to live in small settlements with their extended family and eat a largely plant-based diet, he said. There might also be good and bad types of inflammation, Dr Cohen said. While the indigenous populations did experience inflammation from infection, those levels weren't tied to chronic disease later in life. That could mean that the presence of inflammation alone isn't as bad as we thought, he added. It's not clear if people can do anything to manage inflammageing late in life. People who want to age more healthily may be better off eating better and exercising more to regulate immune response in the long run, instead of focusing on drugs or supplements advertised to target inflammation, Dr Cohen said.

Walking 7,000 steps a day a huge boost to health: Research
Walking 7,000 steps a day a huge boost to health: Research

CNA

time5 days ago

  • CNA

Walking 7,000 steps a day a huge boost to health: Research

People who walk 7,000 steps a day have a dramatically lower risk of a broad range of serious health problems, the largest review of the evidence yet said Thursday. The most widely promoted target for people tracking their number of steps is 10,000 – but that figure reportedly originally came from a 1960s marketing campaign for a Japanese pedometer. To find a more scientific target, an international team of researchers sifted through 57 previous studies that covered 160,000 people. The results published in the Lancet Public Health journal found that walking 7,000 steps a day nearly halved people's risk of early death from all causes, compared to 2,000 steps. The study also looked into health problems not previously covered by research into step counts. Walking 7,000 steps a day was linked to people's risk of dementia falling by 38 per cent, depression dropping 22 per cent and diabetes decreasing 14 per cent. It was also associated with lower rates of cancer and falls, though the researchers warned this was based on less evidence. "You don't need to hit 10,000 steps a day to get major health benefits," Paddy Dempsey, a study co-author and medical researcher at Cambridge University, told AFP. "The biggest gains happen before 7,000 steps, and then benefits tend to level off," he said. While people's speeds vary widely, 7,000 steps adds up to roughly an hour of walking throughout the day. Dempsey emphasised that people already managing 10,000 or more steps should keep it up. But he had a message for people who might find 7,000 steps daunting: "Don't be discouraged". "If you're only getting 2,000–3,000 steps a day, aim to add an extra 1,000 steps. That's just 10–15 minutes of light walking spread across the day," he said. Andrew Scott, a researcher at the University of Portsmouth not involved in the study, said that "it demonstrates that overall more is always better". "People should not focus too much on the numbers, particularly on days where activity is limited," he added. The World Health Organization recommends at least 150 minutes of moderate to intense physical activity a week. Nearly a third of people worldwide do not reach this target, according to the WHO.

Trump Administration Seeks New Allies for Golden Dome Defense Program Amid Musk Fallout
Trump Administration Seeks New Allies for Golden Dome Defense Program Amid Musk Fallout

International Business Times

time6 days ago

  • International Business Times

Trump Administration Seeks New Allies for Golden Dome Defense Program Amid Musk Fallout

The Trump administration is actively expanding its list of potential partners for the Golden Dome missile defense system, signaling a shift away from heavy reliance on Elon Musk's SpaceX. Sources say defense officials are now courting Amazon's Project Kuiper and major military contractors to diversify involvement in the $175 billion initiative. This move follows a breakdown in relations between US President Trump and Musk, culminating in a public dispute on June 5. Even before the fallout, the Pentagon and White House had quietly begun seeking alternatives to avoid overdependence on SpaceX, which currently leads with its Starlink and Starshield satellite networks supporting military communications. SpaceX, while still favored for launch contracts due to its record of over 9,000 satellite deployments, may see its share in the project reduced. Musk previously stated the company had not bid for Golden Dome and prefers to focus on space exploration. The company declined to comment further. Amazon's Project Kuiper, though still in early deployment with only 78 of a planned 3,000 satellites launched, has drawn new interest from the Pentagon. Executive Chairman Jeff Bezos confirmed earlier that Kuiper's constellation would have defense applications. A company spokesperson declined to comment on current talks. Meanwhile, traditional defense firms including Lockheed Martin, Northrop Grumman, and L3Harris are actively in discussions to support the Golden Dome. Lockheed said it is ready to assist, while L3Harris noted increased demand for its missile tracking systems. Northrop is developing a space-based interceptor, enhancing the shield's strike-back potential from orbit. The administration's outreach now includes emerging space tech firms like Rocket Lab and Stoke Space. Officials confirm that as the program matures, individual launch contracts will be opened for competitive bidding. A senior U.S. official said Kuiper is considered a top candidate for satellite deployment. Congress has already increased satellite funding, granting the U.S. Space Force $13 billion to accelerate production. The first $25 billion allocation under Trump's defense spending bill is expected soon. Security concerns remain, however, as commercial satellites must be fortified against cyber threats and electronic warfare. Golden Dome, modeled after Israel's Iron Dome but on a global scale, is central to Trump's rapid defense push. Under a directive from Defense Secretary Pete Hegseth, Space Force General Michael Guetlein must deliver a complete implementation plan within 120 days of his July 17 Senate confirmation. The program's future could reshape space militarization and global defense dynamics, while also redefining the tech-defense industry landscape amid political shifts and rivalries. (With inputs from agencies)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store